Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunomodulator”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02834052
What this trial is testing

Pembrolizumab + Poly-ICLC in MRP Colon Cancer

Who this might be right for
Metastatic Colon CancerSolid Tumor
Asha Nayak 42
Large-scale testing (Phase 3)Study completedNCT00778843
What this trial is testing

Antioxidant and Immunomodulator Properties of Viusid in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Catalysis SL 60
Early research (Phase 1)Study completedNCT01711684
What this trial is testing

Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP)

Who this might be right for
Neoplasm MetastasisMelanoma
Rockefeller University 6
Not applicableLooking for participantsNCT05047094
What this trial is testing

Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaSkin CancerMetastatic Head-and-neck Squamous-cell Carcinoma
Alpha Tau Medical LTD. 48
Not applicableStudy completedNCT01749813
What this trial is testing

Specific Carbohydrate Diet as Maintenance Therapy in Crohn's Disease

Who this might be right for
Crohn's Disease
Stanford University 8
Testing effectiveness (Phase 2)Ended earlyNCT00145145
What this trial is testing

Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Ludwig Institute for Cancer Research 1
Not applicableStudy completedNCT06888232
What this trial is testing

Safety and Efficacy of Immunomodulator Drug Thalidomide in Multi-transfused Thalassemia Patients

Who this might be right for
Thalassemia
Muhammad Aamir Latif 121
Early research (Phase 1)Study completedNCT02149225
What this trial is testing

GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients

Who this might be right for
Glioblastoma
Immatics Biotechnologies GmbH 16
Testing effectiveness (Phase 2)Study completedNCT01141491
What this trial is testing

Trivalent Ganglioside Vaccine With Immunological Adjuvant or Immunological Adjuvant Alone in Metastatic Sarcoma Patients Who Are Rendered Disease Free

Who this might be right for
Sarcoma
MabVax Therapeutics, Inc. 136
Testing effectiveness (Phase 2)Study completedNCT01208194
What this trial is testing

Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma

Who this might be right for
Advanced Colorectal Carcinoma
Mologen AG 59
Testing effectiveness (Phase 2)Active Not RecruitingNCT05775159
What this trial is testing

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

Who this might be right for
Hepatocellular CarcinomaBiliary Tract Cancer
AstraZeneca 294
Not applicableWithdrawnNCT01165645
What this trial is testing

Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaStage I Adult Hodgkin LymphomaStage II Adult Hodgkin Lymphoma+2 more
Mayo Clinic
Testing effectiveness (Phase 2)UnknownNCT03066986
What this trial is testing

Study of Sting Challenge and Serological Responses to Jack Jumper Venom Immunotherapy With Inulin as Adjuvant (Jumpvax)

Who this might be right for
Ant StingImmunotherapy
Central Adelaide Local Health Network Incorporated 40
Large-scale testing (Phase 3)Study completedNCT01223690
What this trial is testing

Clarithromycin as Immunomodulator for the Management of Sepsis

Who this might be right for
SepsisSevere SepsisSeptic Shock
University of Athens 600
Post-approval studies (Phase 4)Looking for participantsNCT07280741
What this trial is testing

Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases Under Immunomodulators

Who this might be right for
Autoimmune Rheumatic Diseases
University of Sao Paulo General Hospital 200
Post-approval studies (Phase 4)UnknownNCT03332329
What this trial is testing

Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis b
Qin Ning 15
Testing effectiveness (Phase 2)Ended earlyNCT05288062
What this trial is testing

Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma+1 more
Mayo Clinic 17
Testing effectiveness (Phase 2)Study completedNCT03093259
What this trial is testing

ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abivax S.A. 32
Not applicableUnknownNCT05797948
What this trial is testing

GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University 20
Not applicableStudy completedNCT00843635
What this trial is testing

Tadalafil in Treating Patients Undergoing Surgery for Cancer of the Oral Cavity or Oropharynx

Who this might be right for
Head and Neck Cancer
Donald T. Weed 35
Next Page